Literature DB >> 8490466

Where are we now with vaccines against AIDS?

G C Schild, E J Stott.   

Abstract

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome--prevention and control; Animals, Laboratory; Clinical Research; Clinical Trials; Diseases; Hiv Infections--prevention and control; Human Volunteers; International Agencies; Organizations; Research Methodology; Un; Vaccines; Viral Diseases; Who

Mesh:

Substances:

Year:  1993        PMID: 8490466      PMCID: PMC1677453          DOI: 10.1136/bmj.306.6883.947

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  15 in total

1.  Intrarectal challenge of macaques vaccinated with formalin-inactivated simian immunodeficiency virus.

Authors:  M P Cranage; A Baskerville; L A Ashworth; M Dennis; N Cook; S Sharpe; G Farrar; J Rose; P A Kitchin; P J Greenaway
Journal:  Lancet       Date:  1992-02-01       Impact factor: 79.321

2.  Anti-cell antibody in macaques.

Authors:  E J Stott
Journal:  Nature       Date:  1991-10-03       Impact factor: 49.962

3.  Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

Authors:  P W Berman; T J Gregory; L Riddle; G R Nakamura; M A Champe; J P Porter; F M Wurm; R D Hershberg; E K Cobb; J W Eichberg
Journal:  Nature       Date:  1990-06-14       Impact factor: 49.962

4.  Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys.

Authors:  P Putkonen; R Thorstensson; L Ghavamzadeh; J Albert; K Hild; G Biberfeld; E Norrby
Journal:  Nature       Date:  1991-08-01       Impact factor: 49.962

5.  Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells.

Authors:  P N Fultz; P Nara; F Barre-Sinoussi; A Chaput; M L Greenberg; E Muchmore; M P Kieny; M Girard
Journal:  Science       Date:  1992-06-19       Impact factor: 47.728

6.  A formalin-inactivated whole SIV vaccine confers protection in macaques.

Authors:  M Murphey-Corb; L N Martin; B Davison-Fairburn; R C Montelaro; M Miller; M West; S Ohkawa; G B Baskin; J Y Zhang; S D Putney
Journal:  Science       Date:  1989-12-08       Impact factor: 47.728

7.  Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.

Authors:  S L Hu; K Abrams; G N Barber; P Moran; J M Zarling; A J Langlois; L Kuller; W R Morton; R E Benveniste
Journal:  Science       Date:  1992-01-24       Impact factor: 47.728

Review 8.  Development of a vaccine for the prevention of AIDS, a critical appraisal.

Authors:  D T Karzon; D P Bolognesi; W C Koff
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

9.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

10.  Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody.

Authors:  E A Emini; W A Schleif; J H Nunberg; A J Conley; Y Eda; S Tokiyoshi; S D Putney; S Matsushita; K E Cobb; C M Jett
Journal:  Nature       Date:  1992-02-20       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.